Paper28545784
Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.
Leonard CE and 5 others. Trends Endocrinol Metab, 2017. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. Papers, record 28545784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28545784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arrhythmias, Cardiac | Major topic |
| Heart Rate | Major topic |
| Hypoglycemic Agents | Major topic |
| Sulfonylurea Compounds | Major topic |
| Animals | |
| Death, Sudden, Cardiac | |
| Diabetes Mellitus, Type 2 | |
| Humans | |
| Incidence | |
| Ischemic Preconditioning, Myocardial |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 HS023898 | AHRQ HHS | United States | K08HS023898 | PubMed and NIH | NIH RePORTER |
| R01 AG025152 | NIA NIH HHS | United States | R01AG025152 | PubMed and NIH | NIH RePORTER |
| R01 DK102694 | NIDDK NIH HHS | United States | R01DK102694 | PubMed and NIH | NIH RePORTER |
References181
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8595627 | KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. | Cardiovasc Res | 1995 | https://conductscience.org/library/papers/8595627 | PubMed |
| 2 | 1819892 | Effects of glibenclamide and tolbutamide on ischemia- and ouabain-induced arrhythmias and membrane potentials of ventricular myocardium from rat and guinea pig. | Zhongguo Yao Li Xue Bao | 1991 | https://conductscience.org/library/papers/1819892 | PubMed |
| 3 | 10409190 | Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K(+) channels in rabbit heart. | Am J Physiol | 1999 | https://conductscience.org/library/papers/10409190 | PubMed |
| 4 | 7713283 | QT prolongation in type 2 diabetes mellitus treated with glibenclamide. | Diabete Metab | 1994 | https://conductscience.org/library/papers/7713283 | PubMed |
| 5 | 12121705 | Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning. | J Surg Res | 2002 | https://conductscience.org/library/papers/12121705 | PubMed |
| 6 | 16966594 | Sudden cardiac death: better understanding of risks, mechanisms, and treatment. | Circulation | 2006 | https://conductscience.org/library/papers/16966594 | PubMed |
| 7 | 9024742 | Blockade of K(ATP) channels with glibenclamide does not abolish preconditioning during demand ischemia. | Am J Cardiol | 1997 | https://conductscience.org/library/papers/9024742 | PubMed |
| 8 | 10539800 | Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction. | Am Heart J | 1999 | https://conductscience.org/library/papers/10539800 | PubMed |
| 9 | 9476676 | Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. | Int J Cardiol | 1997 | https://conductscience.org/library/papers/9476676 | PubMed |
| 10 | 10821820 | Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. | Circulation | 2000 | https://conductscience.org/library/papers/10821820 | PubMed |
| 11 | 24910232 | Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. | Lancet | 2014 | https://conductscience.org/library/papers/24910232 | PubMed |
| 12 | 11004427 | Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels. | J Diabetes Complications | 2000 | https://conductscience.org/library/papers/11004427 | PubMed |
| 13 | 16444778 | Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy. | Diabetes Metab Res Rev | 2006 | https://conductscience.org/library/papers/16444778 | PubMed |
| 14 | 8263798 | Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? | J Pharmacol Exp Ther | 1993 | https://conductscience.org/library/papers/8263798 | PubMed |
| 15 | 20544609 | Diabetes mellitus and sudden cardiac death: what are the data? | Cardiol J | 2010 | https://conductscience.org/library/papers/20544609 | PubMed |
| 16 | 7475053 | Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. | J Cardiovasc Pharmacol | 1995 | https://conductscience.org/library/papers/7475053 | PubMed |
| 17 | 11425777 | Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. | Circulation | 2001 | https://conductscience.org/library/papers/11425777 | PubMed |
| 18 | 2119912 | Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. | Circ Res | 1990 | https://conductscience.org/library/papers/2119912 | PubMed |
| 19 | 10988237 | Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. | Circ Res | 2000 | https://conductscience.org/library/papers/10988237 | PubMed |
| 20 | 7477447 | Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs. | Naunyn Schmiedebergs Arch Pharmacol | 1995 | https://conductscience.org/library/papers/7477447 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41481542 | Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation. | J Physiol | 2026 | https://conductscience.org/library/papers/41481542 | PubMed |
| 41357784 | Exploring the Therapeutic Potential of Antidiabetic Drugs in Cardiac Arrhythmia Management: A Drug Target Mendelian Randomization Study. | J Arrhythm | 2025 | https://conductscience.org/library/papers/41357784 | PubMed |
| 41302503 | Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus. | Molecules | 2025 | https://conductscience.org/library/papers/41302503 | PubMed |
| 39433419 | Do relationships between ambient temperature and serious adverse health outcomes vary among users of different antidiabetes drugs? A retrospective cohort study of US Medicaid beneficiaries with type 2 diabetes. | BMJ Open | 2024 | https://conductscience.org/library/papers/39433419 | PubMed |
| 39336583 | Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39336583 | PubMed |
| 38856903 | Non-radioactive Rb+ Efflux Assay for Screening KATP Channel Modulators. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/38856903 | PubMed |
| 37646176 | Hypoxia Promotes Atrial Tachyarrhythmias via Opening of ATP-Sensitive Potassium Channels. | Circ Arrhythm Electrophysiol | 2023 | https://conductscience.org/library/papers/37646176 | PubMed |
| 36102222 | Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/36102222 | PubMed |
| 36033393 | The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment. | J Immunol Res | 2022 | https://conductscience.org/library/papers/36033393 | PubMed |
| 35207759 | Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension. | J Pers Med | 2022 | https://conductscience.org/library/papers/35207759 | PubMed |
| 35112189 | Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study. | Acta Diabetol | 2022 | https://conductscience.org/library/papers/35112189 | PubMed |
| 34804796 | Unusual T-wave changes and extreme QTc prolongation in a 71-year-old man with asymptomatic COVID infection. | HeartRhythm Case Rep | 2022 | https://conductscience.org/library/papers/34804796 | PubMed |
| 34198942 | Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34198942 | PubMed |
| 33896015 | Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33896015 | PubMed |
| 32784369 | Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor. | Molecules | 2020 | https://conductscience.org/library/papers/32784369 | PubMed |
| 32572080 | Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations. | Sci Rep | 2020 | https://conductscience.org/library/papers/32572080 | PubMed |
| 32098624 | The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety. | Cardiovasc Diabetol | 2020 | https://conductscience.org/library/papers/32098624 | PubMed |
| 31208937 | Methylome-wide association study provides evidence of particulate matter air pollution-associated DNA methylation. | Environ Int | 2019 | https://conductscience.org/library/papers/31208937 | PubMed |
| 30596400 | Functional protection against cardiac diseases depends on ATP-sensitive potassium channels. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/30596400 | PubMed |
| 30564287 | Evaluating the Diabetes-Cardiology interface: a glimpse into the diabetes management of cardiology inpatients in western Sydney's 'diabetes hotspot' and the establishment of a novel model of care. | Diabetol Metab Syndr | 2018 | https://conductscience.org/library/papers/30564287 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCC8 | 6833 | PubTator's text mining | https://conductscience.org/library/genes/6833 | NCBI Gene |
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| ERG | 2078 | PubTator's text mining | https://conductscience.org/library/genes/2078 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28545784
GET https://conductscience.org/api/papers/v1/28545784/references?page=2